FDAClass IFebruary 1, 2023

Advil Liqui Gels recall: Labeling Error

Advil Liqui Gels, Solubilized ibuprofen capsules, 200mg, Pain Reliever Fever Reducer (NSAID), 200 liquid filled capsules, Distributed by: Pfizer, Madison, NJ 07940, UPC 3 0573 0169 49 3

Why was Advil Liqui Gels recalled?

Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back

What should I do if I have this product?

Review the official FDA enforcement record for current instructions.

What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.

Is my product affected?

Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.

Which lot codes, UPCs or models are affected?

Lot: R94065, Exp 02/29/2024

Product
Advil Liqui Gels, Solubilized ibuprofen capsules, 200mg, Pain Reliever Fever Reducer (NSAID), 200 liquid filled capsules, Distributed by: Pfizer, Madison, NJ 07940, UPC 3 0573 0169 49 3
Recalling firm
Glaxosmithkline Consumer Healthcare Holdings DBA Haleon
Quantity
88,380 capsules
Distribution
Nationwide in the USA.
Recall date
February 1, 2023
Classification
Class I
Status
Terminated
Agency
FDA (drug)
Open FDA enforcement record Latest recalls